• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水痘监测的演变——部分州,2000-2010 年。

Evolution of varicella surveillance--selected states, 2000-2010.

出版信息

MMWR Morb Mortal Wkly Rep. 2012 Aug 17;61(32):609-12.

PMID:22895384
Abstract

Varicella surveillance practices have evolved since varicella first became nationally notifiable in 1972 (1) (Table 1). Because national surveillance data were not adequate for monitoring the impact of varicella vaccine when it became available in the United States, active surveillance for varicella was established in sentinel sites in 1995 (1,2). With declines in varicella incidence after 1 dose of varicella vaccine was added to the routine childhood vaccination schedule in 1996 (3) and a second dose was recommended in 2006 (4), the number of cases of varicella in the active surveillance sites became insufficient to monitor further impact of vaccination. CDC evaluated varicella surveillance data reported via the National Notifiable Diseases Surveillance System (NNDSS) during 2000-2010 to determine whether these data might now be adequate for monitoring vaccination impact. By 2010, a total of 39 states required reporting of varicella cases, 38 states were conducting passive case-based surveillance, and 31 met CDC's ad hoc criteria for adequate and consistent reporting. Varicella incidence in the states that met these criteria declined 79% overall, from 43 per 100,000 population in 2000 to nine in 2010. While 1 dose of varicella vaccine was recommended, incidence declined 43% during 2000-2005, and after a second dose was added to the routine childhood schedule, incidence declined 72% during 2006-2010. State varicella surveillance data reported to CDC through NNDSS are now adequate for monitoring trends in varicella incidence, but continued strengthening of the surveillance system and participation of all states is needed.

摘要

自从水痘于 1972 年首次成为全国法定报告疾病(1)(表 1)以来,水痘监测实践一直在发展。由于国家监测数据不足以监测在美国可用的水痘疫苗的影响,1995 年在哨点设立了水痘主动监测(1,2)。自 1996 年常规儿童免疫接种计划中增加一剂水痘疫苗后,水痘发病率下降(3),并于 2006 年推荐接种第二剂(4),主动监测点的水痘病例数量不足以进一步监测疫苗接种的影响。CDC 评估了通过国家法定传染病监测系统(NNDSS)报告的 2000-2010 年水痘监测数据,以确定这些数据现在是否足以监测疫苗接种的影响。到 2010 年,共有 39 个州要求报告水痘病例,38 个州正在进行基于病例的被动监测,31 个州符合 CDC 关于充分和一致报告的临时标准。符合这些标准的州的水痘发病率总体下降了 79%,从 2000 年的每 10 万人 43 例下降到 2010 年的 9 例。虽然推荐接种一剂水痘疫苗,但 2000-2005 年发病率下降了 43%,当第二剂疫苗被添加到常规儿童接种计划中后,2006-2010 年发病率下降了 72%。通过 NNDSS 向 CDC 报告的州水痘监测数据现在足以监测水痘发病率的趋势,但需要继续加强监测系统并让所有州参与。

相似文献

1
Evolution of varicella surveillance--selected states, 2000-2010.水痘监测的演变——部分州,2000-2010 年。
MMWR Morb Mortal Wkly Rep. 2012 Aug 17;61(32):609-12.
2
Varicella surveillance practices--United States, 2004.2004年美国水痘监测实践
MMWR Morb Mortal Wkly Rep. 2006 Oct 20;55(41):1126-9.
3
Epidemiology of Varicella During the 2-Dose Varicella Vaccination Program - United States, 2005-2014.2005-2014 年美国 2 剂次水痘疫苗接种项目期间水痘的流行病学。
MMWR Morb Mortal Wkly Rep. 2016 Sep 2;65(34):902-5. doi: 10.15585/mmwr.mm6534a4.
4
Evaluation of varicella reporting to the National Notifiable Disease Surveillance System--United States, 1972-1997.1972 - 1997年美国向国家法定传染病监测系统报告水痘情况的评估
MMWR Morb Mortal Wkly Rep. 1999 Jan 29;48(3):55-8.
5
Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.1995 - 2005年美国主动监测点水痘流行病学的变化
J Infect Dis. 2008 Mar 1;197 Suppl 2:S71-5. doi: 10.1086/522156.
6
Decline in annual incidence of varicella--selected states, 1990-2001.1990 - 2001年部分州水痘年发病率的下降情况
MMWR Morb Mortal Wkly Rep. 2003 Sep 19;52(37):884-5.
7
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?一剂水痘疫苗无法预防学校爆发疫情:是时候接种第二剂了吗?
Pediatrics. 2006 Jun;117(6):e1070-7. doi: 10.1542/peds.2005-2085.
8
Varicella outbreak reporting, response, management, and national surveillance.水痘疫情报告、应对、管理及国家监测。
J Infect Dis. 2008 Mar 1;197 Suppl 2:S108-13. doi: 10.1086/522138.
9
Varicella among adults: data from an active surveillance project, 1995-2005.成人水痘:1995 - 2005年一项主动监测项目的数据
J Infect Dis. 2008 Mar 1;197 Suppl 2:S94-S100. doi: 10.1086/522155.
10
Epidemiology of varicella hospitalizations in the United States, 1995-2005.1995 - 2005年美国水痘住院情况的流行病学研究
J Infect Dis. 2008 Mar 1;197 Suppl 2:S120-6. doi: 10.1086/522146.

引用本文的文献

1
Analysis on the epidemiological characteristics of varicella and breakthrough case from 2014 to 2022 in Qingyang City.庆阳市 2014 年至 2022 年水痘流行病学特征及突破病例分析。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2224075. doi: 10.1080/21645515.2023.2224075. Epub 2023 Jun 22.
2
Status of Herpes Zoster and Herpes Zoster Vaccines in 2023: A position paper.2023 年带状疱疹和带状疱疹疫苗的现状:立场文件。
Rev Esp Quimioter. 2023 Jun;36(3):223-235. doi: 10.37201/req/004.2023. Epub 2023 Feb 8.
3
Changing Epidemiology of Varicella Outbreaks in the United States During the Varicella Vaccination Program, 1995-2019.
美国水痘疫苗接种计划实施期间(1995-2019 年)水痘暴发的流行情况变化。
J Infect Dis. 2022 Oct 21;226(Suppl 4):S400-S406. doi: 10.1093/infdis/jiac214.
4
Syndromic Surveillance as a Tool for Case-Based Varicella Reporting in Georgia, 2016-2019.综合征监测作为佐治亚州基于病例的水痘报告工具,2016-2019 年。
Public Health Rep. 2022 Nov-Dec;137(6):1070-1078. doi: 10.1177/00333549211050897. Epub 2021 Oct 13.
5
Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.水痘带状疱疹病毒:儿童和成人中风的常见病因。
J Stroke Cerebrovasc Dis. 2016 Jul;25(7):1561-1569. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.052. Epub 2016 Apr 29.
6
Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era.两剂次时代水痘疫苗在预防社区传播中的有效性
Pediatrics. 2016 Apr;137(4). doi: 10.1542/peds.2015-2802. Epub 2016 Mar 14.
7
Zeroing in on zoster: A tale of many disorders produced by one virus.聚焦带状疱疹:一种病毒引发多种疾病的故事。
J Neurol Sci. 2015 Nov 15;358(1-2):38-45. doi: 10.1016/j.jns.2015.10.004. Epub 2015 Oct 3.
8
Trends in varicella mortality in the United States: Data from vital statistics and the national surveillance system.美国水痘死亡率趋势:来自人口动态统计数据及国家监测系统的数据
Hum Vaccin Immunother. 2015;11(3):662-8. doi: 10.1080/21645515.2015.1008880.
9
An evaluation of voluntary 2-dose varicella vaccination coverage in New York City public schools.纽约市公立学校自愿接种两剂水痘疫苗的覆盖率评估。
Am J Public Health. 2015 May;105(5):972-9. doi: 10.2105/AJPH.2014.302229. Epub 2014 Dec 18.
10
Assessment of varicella surveillance and outbreak control practices - United States, 2012.水痘监测和暴发控制措施评估 - 美国,2012 年。
MMWR Morb Mortal Wkly Rep. 2014 Sep 12;63(36):785-8.